-
-
-
-
-
-
-
XORTX Therapeutics Inc (XRTX) Announces USD $3 Million Offering Up to 3.4 Million Shares at $0.88 Each
-
-
-
-
-
-
-
XORTX Therapeutics (XRTX) Clarifies Timing for Reverse Share Split
-
-
-
-
-
-
-
XORTX Sponsored Study Selected for Presentation at the American Society of Nephrology – Kidney Week 2023
-
-
-
-
-
-
-
XORTX Reminds Shareholders to Vote ahead of the Proxy Voting Deadline for the Company’s Upcoming Annual and Special Meeting of Shareholders
-
-
-
-
-
-
-
XORTX Announces Type D Meeting with FDA to be held May 1, 2023
-
-
-
-
-
-
-
XORTX Announces Completion of Dosing in XRX-OXY-101 Clinical Study
-
-
-
-
-
-
-
XORTX Presents New Proof of Concept Data at American Society of Nephrology
-
15,384 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

